STAT3 mediates bone marrow mesenchymal stem cell VEGF production.
about
TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.Gender dimorphisms in progenitor and stem cell function in cardiovascular disease.Proinflammatory stem cell signaling in cardiac ischemiaMDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-λ) signaling.The stem cell adjuvant with Exendin-4 repairs the heart after myocardial infarction via STAT3 activation.Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1alpha mediates estrogen receptor-alpha-induced mesenchymal stem cell vascular endothelial growth factor productionElectro-acupuncture at Conception and Governor vessels and transplantation of umbilical cord blood-derived mesenchymal stem cells for treating cerebral ischemia/reperfusion injurySca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusionSecretion of immunoregulatory cytokines by mesenchymal stem cells.Receptor "hijacking" by malignant glioma cells: a tactic for tumor progressionAromatic amino acid activation of signaling pathways in bone marrow mesenchymal stem cells depends on oxygen tensionDensity of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.Local renin-angiotensin system regulates hypoxia-induced vascular endothelial growth factor synthesis in mesenchymal stem cellsHarnessing the mesenchymal stem cell secretome for the treatment of cardiovascular diseaseSTAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.STAT3 Activation in Circulating Monocytes Contributes to Neovascular Age-Related Macular Degeneration.Does adipose tissue-derived stem cell therapy improve graft quality in freshly grafted ovaries?Harvest tissue source does not alter the protective power of stromal cell therapy after intestinal ischemia and reperfusion injury.Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke.Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice.Stem cells as a potential future treatment of pediatric intestinal disorders.Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions.High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferationHuman fetal mesenchymal stem cell secretome enhances bone consolidation in distraction osteogenesis.Bmp-12 activates tenogenic pathway in human adipose stem cells and affects their immunomodulatory and secretory propertiesVascular endothelial growth factor signaling in acute myeloid leukemia.Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases.microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling.Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma.The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.Salvianolic Acids Enhance Cerebral Angiogenesis and Neurological Recovery by Activating JAK2/STAT3 Signaling Pathway after Ischemic Stroke in Mice.Endothelial invasive response in a co-culture model with physically-induced osteodifferentiation.Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells.High glucose attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis.Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: tissue-specific stem cells.Neurogenic differentiation capacity of subacromial bursal tissue-derived stem cells.Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.Distinct patterns of histone modifications at cardiac-specific gene promoters between cardiac stem cells and mesenchymal stem cells.Vascular niche contribution to age-associated neural stem cell dysfunction.
P2860
Q33769592-F28C0DB9-472E-447C-A6F2-586329618CB2Q33771819-F879474D-1567-4A55-97E0-38BCAD07BB2FQ33858319-1AC3BCC7-1813-4D0C-8D96-EEB084913FA1Q33975551-63D9E3EF-5CA9-4BF5-8538-2DBC8620C4CEQ34011497-C4DBBC4B-F862-40AF-B38C-585EE562FDFCQ34089612-BFF15733-90E2-4C87-89D1-633F4BC9DB58Q34096356-1B8B3DE5-C143-4BE4-BFE1-9C9D72D493FFQ34110874-2B47FFCD-7698-4B4E-BD32-EA2BE9FB1839Q34259098-EC08F694-2DC5-4410-A9C4-3BC4D7BAEF63Q34313996-D63B082A-478F-471A-B129-031990280FE8Q35146498-8AF96E73-B8D4-4A01-8F10-D7A24C5E3916Q35191027-442D4207-621B-4C68-9C39-5B87C33E83B3Q35632070-347C6DE9-599E-4BA8-B881-A20744745641Q35804026-BA67BEA4-3E0C-4BB3-8593-1F19B2F8E431Q35925825-4CC97063-FCCE-4FA8-BCE3-7C3E6CC51101Q35968159-5E7F8A4A-D99F-406B-91BF-4144AB1347D4Q36086613-248E2637-D333-45C5-B0C4-3B20BE3B41A3Q36114386-000AF6B0-918F-4FAC-92AB-FF63C9D09D8BQ36249538-EE5CEF2A-8F14-4215-A78C-5F4A5CA812DDQ36411048-B805F9FE-6169-44CF-80FB-8320B7AEF62BQ36976592-7ADE139A-B38D-4074-8E3E-CA3CFBB1DD6CQ36995124-E58A2E74-828D-464C-A363-AE80D1AE6400Q37217978-96F3F9C3-0CEB-4541-A4F3-59D4354E7191Q37246154-D6DEB278-2DF0-4873-9D81-95ECEBBB87E9Q37650872-ADDC3D30-9DC0-44EE-9F1D-18E2311F408DQ38029546-7EB4D035-DCA8-4AA2-B3EB-6B3468B31C81Q38177689-8FC382E9-CE83-476F-A330-4397E191270DQ38324467-DE0FB9B5-BE3A-42F7-8AEA-300F977879CBQ38374930-DCAA0CE1-8E7F-4BCD-9900-AD8D700144D1Q38442767-B6F81D42-8E02-416E-9AD1-0135693AA564Q38644219-61CC164B-8F85-4C2D-B8D0-A6CF36B82134Q39331624-CDE1F4F5-4D76-471A-9358-820286B18E7DQ39712429-E2DEAED0-5656-4EAF-B371-07181E2E6F50Q41966597-A6655EA8-54EE-4A26-AAF0-B97B29485C68Q42366665-8C11FFA3-83C0-4D7D-94C2-AC7B956A735EQ42374637-22EF8FBA-B5DD-4A5F-B919-33945CD1B9F0Q45854385-944E31F2-2CA1-47A7-A81A-12D439B2A004Q46705968-0811D9EB-A349-4267-8F98-5455A19BCE8BQ48033062-DC11F08D-6585-4A7B-AFCD-2F387535C6B3Q48157394-425B5AAB-3D7F-48E1-A7D9-D178A1B5D6F0
P2860
STAT3 mediates bone marrow mesenchymal stem cell VEGF production.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
STAT3 mediates bone marrow mesenchymal stem cell VEGF production.
@ast
STAT3 mediates bone marrow mesenchymal stem cell VEGF production.
@en
type
label
STAT3 mediates bone marrow mesenchymal stem cell VEGF production.
@ast
STAT3 mediates bone marrow mesenchymal stem cell VEGF production.
@en
prefLabel
STAT3 mediates bone marrow mesenchymal stem cell VEGF production.
@ast
STAT3 mediates bone marrow mesenchymal stem cell VEGF production.
@en
P2093
P2860
P1476
STAT3 mediates bone marrow mesenchymal stem cell VEGF production.
@en
P2093
Daniel R Meldrum
Kirstan K Meldrum
Meijing Wang
Paul Crisostomo
Troy Markel
Wenjun Zhang
P2860
P304
P356
10.1016/J.YJMCC.2007.04.010
P577
2007-04-24T00:00:00Z